PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'

Go back to PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 68.68 --0 (-0%)
Previous Close $68.68    52 Week High $35.40 
Open $68.68    52 Week Low $4.03 
Day High $68.68    P/E 7.31 
Day Low $68.68    EPS $9.40 
Volume 419